Large numbers of a wide variety of species of ornamental fishes are sold throughout the world to hobbyists for home aquaria and are also used extensively in a number of areas of biological research (5) . Many of these fish subsequently succumb to bacterial diseases, the most common being fin and tail rot, furunculosis, gill infections, piscine mycobacteriosis, columnaris disease, and infectious hemorrhagic septicemia (6) . A number of products are manufactured and marketed for the therapy and prophylaxis of these diseases. Some of these products are liquid formulations containing such compounds as the acridines, formaldehyde, malachite green, methylene blue, potassium permanganate, quaternary ammonium compounds, or silver oxide, compounds that do not exhibit selective toxicity against bacterial cells. The antibacterial activity of 14 of these liquid formulations was tested, and it was shown that when used at the dilutions recommended by the manufacturers, the products failed to inhibit the growth of bacterial species known to be potential pathogens of freshwater fishes and failed to reduce significantly the bacterial numbers in water containing fish (18) . Another group of products is available to treat diseases of ornamental fishes. These solid formulations are reputed to contain compounds known to exhibit selective toxicity against bacteria. These include erythromycin, neomycin, a nitrofuran, penicillin, streptomycin, the sulfa compounds, and tetracycline. Because the previous study had demonstrated the liquid formulations to be inadequate, it was thought desirable to continue the previous study to ascertain the effectiveness of these solid formulations.
MATERIALS AND METHODS Products tested. Products 1, 2, 3, 4, 5, 6, and 8
were purchased from commercial outlets in Victoria, British Columbia; product 7 was supplied by the manufacturer. This latter product contained 6-hydroxymethyl-2-[2-(5-nitro-2-furyl)vinyl]pyridine (NFP) .This compound has recently been marketed as an antibacterial specifically useful for fish culture. The products were marketed by three manufacturers in the United States for the therapy and prophylaxis of infections of aquarium fishes. The active antibacterial ingredients in each formulation, the weight of each antibacterial ingredient per capsule or tablet, and the manufacturers' recommended usage concentrations expressed in terms of the active antibacterial components are shown in Table 1 . Additional information on the presence or absence of other active ingredients in product 7 was not available. Pure samples of the active, selectively toxic compounds present in the above formulations were also tested for comparative purposes. Erythromycin was purchased from Sigma Chemicals Co., and potassium penicillin, neomycin sulfate, sodium sulfamerazine, sodium sulfamethazine, sodium sulfathiazole, streptomycin sulfate, and tetracycline hydrochloride were purchased from Nutritional Biochemicals Corp. Pure (6) . These species of Aeromonas, Mycobacterium, and Pseudomonas have also been isolated from a variety of clinical diseases in man (2, 10, 21) .
Escherichia coli ATCC 11775, Klebsiella pneumoniae ATCC 10031-1, Pseudomonas aeruginosa ATCC 15442, Salmonella typhi ATCC 167-P, and Staphylococcus aureus ATCC 6538 and ATCC 6538 P were chosen for study because these species are recommended for assays of antibacterial compounds (4, 11, 12) . These species are also potential human pathogens (22) . Species of Aeromonas, Pseudomonas, and Enterobacteriaceae are common in aquarium water (19) . Bacillus subtilis ATCC 6633 was chosen because of its ability to form spores and because Bacillus species are common in fish feeds (20) . A spore suspension was used in assays.
Preparation of inocula. Different cultural conditions were required to prepare inocula of the test species for the antibacterial assays. Cultures of E. coli, K. pneumoniae, P. aeruginosa, Salmonella typhi, and Staphylococcus aureus were incubated at 37 C for 24 h in antibiotic assay broth (BBL); A. hydrophila, A. liquefaciens, P. putida, P. fluorescens, and V. anguillarum were incubated at 30 C for 24 h. A. salmonicida was grown at 30 C for 48 h. The Cytophaga species, M. fortuitum, and M. marinum were grown on Penassay agar slants at 30 C for 48 h, and the growth on each slant was suspended in antibiotic assay broth. The B. subtilis spore suspension was prepared by the method of the Association of Official Analytical Chemists (4). This suspension contained 3 x 108 viable spores per ml. All other cultures were adjusted to contain approximately 108 cells per ml. These cultures were then used to assay the bacteriostatic properties of the test formulations.
Bacteriostatic activity of products. The dilution of each test product that prevented the growth of each test species was determined by serial tube dilution, using the method described by Kavanagh (11) . Duplicate twofold dilutions of the test product were prepared in broth. Compounds containing erythromycin, NFP, neomycin sulfate, penicillin, streptomycin sulfate, or tetracycline hydrochloride were assayed in antibiotic assay broth (pH 7.0). Mueller-Hinton broth (BBL) (pH 7.4) was used for assays of products containing sulfa compounds. Each 5-ml dilution was then inoculated with 0.03 ml of the appropriate inoculum culture and incubated at 30 C for 96 h.
Assays with E. coli, K. pneumoniae, P. aeruginosa, Salmonella typhi, and Staphylococcus aureus were incubated at 37 C for 96 h. Tubes were then examined for the presence or absence of growth of the test species.
Antibacterial activity of products in aquaria holding fish. The ability of the products to reduce the viable aerobic bacterial count in the aquarium water in the presence of goldfish (Carassius auratus) was generally tested at one, two, and four times the concentration recommended by the manufacturers (18) . The effect of the control antibacterial compounds on the viable bacterial numbers was also tested. The concentrations chosen were based on the highest concentrations added to commercial test disks used to determine the antibiotic susceptibility of ANTIMICROB. AG. CHEMOTHER.
on October 2, 2017 by guest http://aac.asm.org/ Downloaded from gram-negative species. Hence, assays of the control antibacterial compounds were generally performed at one, two, and four times this concentration. In several experiments,, concentrations higher than these were also tested. The fish were acclimatized in a holding aquarium for at least 7 days before the assays. The bioassays were performed as recommended by the American Public Health Association (3) in 6-liter round glass jars, each containing 5 liters of distilled water (adjusted to pH 7). The jars were aerated at 1 liter/min and held at 22 C. Ten goldfish (mean weight, 1.2 g; range of weights, 0.9 to 1.6 g) were placed in each of four assay jars. The fish were placed in the test squarium 48 h before the addition of the test formulation and were not fed until the end of the bioassay. The pH of the water in the aquaria was between pH 6.5 and pH 6.8 immediately before addition of the test formulation. The formulation under test was then added at the appropriate concentration to each of three aquaria. The fourth was maintained as a control. In assays with NFP or tetracycline, the jars were covered with aluminum foil to minimize photodecomposition of the antibacterial compound. Each jar was sampled immediately before addition of the product (zero time) as well as 0.5, 1, 3, 6, 12, 24, 48, and 72 h after addition of the product. The viable bacterial load present in these water samples was determined by the drop pipette method of Miles and Misra (13) . The count procedure used standard methods agar (BBL) plates and duplicate serial dilutions in sterile buffered water. The plates were incubated at 20 C for 72 h, and the colonies were then counted.
RESULTS
The concentration of active ingredients of each formulation required to inhibit growth of the test species is shown in produced bacteriostasis with 500 ,ug of erythromycin per ml. In product 7 more than 1.6 ,ug of NFP per ml was required to inhibit all the test CuSO, to the neomycin in product 1 enhances the antibacterial activity of the formulation, whereas merbromin enhances the antibacterial activity of streptomycin in product 3. Acriflavine appears to enhance the antibacterial activity of sulfathiazole in product 4, and the combination of three sulfa compounds with neomycin in product 5 has markedly greater antibacterial activity than that displayed by the individual compounds or by triple sulfa alone.
The numbers of viable bacteria in the water of aquaria containing goldfish were reduced by product 1 from 107 to 103 per ml within 6 h (Table 4) . However, when used at the concentration recommended by the manufacturer, five of the assay fish were dead within 90 min of the addition of the formulation to the aquarium. An additional four dead fish were removed after 6 h, and the, remaining fish was dead at 12 h. At the higher concentrations tested, all the fish were dead 6 h after addition of the formulation. Fish mortalities were also obtained when the experiment was repeated with a separate batch of fish. In this second experiment, three assay fish were dead after 24 h in the aquarium containing the concentration recommended by the manufacturer. Another two fish were dead after 48 h. At twice this concentration, seven fish died in the first 6 h and the remainder were dead at 12 h. At four times the recommended concentration, all 10 fish were dead within 4 h. When product 2 was used at four, eight, and sixteen times the recommended concentration, the viable bacterial numbers were only lowered to 105 viable cells per ml at 24 h. This was also the case when products 3, 4, 5, 6, 7, and 8 were added to the aquaria at four times the recommended concentration. Moreover, four dead fish were removed from the aquarium containing 42. 4 ,ug of erythromycin per ml at the end of the 72-h assay period. It should be noted that although the total count was generally only reduced to 105 viable cells per ml in the aquaria, there was an effect on the bacterial species present. Generally, one or two colony types were found to predominate in aquaria to which formulations had been added, whereas numerous colony types were present in the control aquaria. It should also be noted that in several assays, the viable bacterial numbers in the water of the control aquaria decreased during the assay period. This probably reflects the attachment of many of the organisms to the surfaces of the aquaria. Table 5 shows the effect of the standard antibacterial compounds on the viable bacterial numbers in test aquarium water. Even when added to the water at concentrations six times higher than that recommended in the case of erythromycin and tetracycline and 167 times higher in the case of streptomycin, the antibacterial compounds failed to reduce the viable VOL. 6, 1974 on October 2, 2017 by guest http://aac.asm.org/ (9) . In the last decade, strains of bacteria resistant to many antibacterial agents have been isolated, and the incidence of these antibacterial-resistant organisms in the environment appears to be on the increase (15) . Not unexpectedly, possession of the property of antibiotic resistance by bacteria causing disease in man has become a matter of considerable concern.
There seems little doubt that the incidence of such antibiotic-resistant strains reflects the widespread use of antibiotics (15) . The resistance can arise by a number of mechanisms (9, 15) , but whatever the route whereby resistance appears in a hitherto susceptible cell, selection pressure most operate if that cell is to become a major component of the bacterial population. There is no doubt that once a resistant cell has emerged, selection with appropriate antibiotics when they are present will lead to the displacement of the susceptible population by a resistant population (15) . Conversely, withdrawal of the antibiotics commonly leads to a decrease in the number of resistant organisms encountered (15) . ing human and animal disease, controls have been imposed on the sales of antibacterial agents for the therapy and prophylaxis of human and animal disease (7, 14, 17) . Such restrictions do not apply to the sale of antibiotics for the therapy and prophylaxis of ornamental fishes. People can purchase products containing erythromycin, neomycin, nitrofuran, penicillin, streptomycin, sulfa compounds, or tetracycline from a large number of retail outlets in North America for use in their household aquaria. Even if these formulations were effective in controlling fish disease, the lack of restrictions would not be desirable and obviously deserves consideration by the appropriate authorities.
The method most commonly used to treat diseases of ornamental fishes is to bathe the fish in the water-soluble antibacterial compound (8) . Our results show that the prescribed levels are likely to be subtherapeutic since they fail to inhibit the growth of bacterial species known to cause infections in aquarium fishes and species commonly found in aquarium water. The results also show that markedly higher levels of the formulations often fail to significantly decrease the numbers of viable bacteria in the aquarium water. Moreover, one of the more effective antibacterial formulations was toxic to the fish. It is worth noting that control of bacterial growth in household aquaria may further be complicated by the presence of sand, plants, and food, since these will reduce the efficiency of the antibacterial compound by direct inactivation or by mechanically protecting the bacteria from attack. In view of the apparent lack of effect on the bacteria in the aquarium water, the formulations would probably be unable to reduce tha viable bacterial numbers of surface infections of the fish. In addition, although few studies have directly compared drug levels attained by different routes of administration, experience has taught that therapeutic tissue levels can rarely be attained by bathing fish in chemotherapeutics (8) . For example, less than 3% of the neomycin reaching the alimentary tract is absorbed through the gut wall.
Various antibiotics and synthetic chemotherapeutics have been used for cultured fish as feed additives in various contries to prevent and treat various infections. They have sometimes been administered directly into fish pond water to control fish infections. Fish pathogens carrying transferable drug resistance factors have been reported. (1) . It is likely that bacteria carrying transferable drug resistance factors will also emerge either in household aquaria containing ornamental fish or in the aquaria of the distributors of the ornamental fishes if antibiotics are used to treat the fish in these situations. This is undesirable, especially since water containing ornamental fish has been found to contain bacterial species that are potential pathogens of man (19) . The potential public health risk of water containing drugresistant bacteria can readily be seen since aquaria containing ornamental fish are found in schools, eating establishments, shopping centers, retails stores, hospital wards, homes for the elderly, and doctors' and dentists' offices.
In addition to the potential for rapid emergence of strains of multidrug-resistant bacteria by virtue of their acquisition of transferable drug resistance factors, a rapid emergence of resistance to streptomycin in vitro can also occur by the so-called "one-step" resistance pattern (9) . Gram-negative species and Mycobacterium in particular can be made to yield mutants with a high resistance to streptomycin (9) . In fact, aquarium-borne mycobacterioses that are refractory to chemotherapy have already been reported (2, 10). Therefore, it seems undesirable to continue to allow the unrestricted sale of streptomycin and other antibiotics for aquarium use.
The philosophy of the use of bacteriostatic antibiotics to bathe fish also needs to be reevaluated. The in vivo success of chemotherapy with bacteriostatic compounds often depends on the ability of these compounds to control bacterial growth until the immune response can cope with the invaders. This is not likely to be applicable when poikilothermic species are bathed in such bacteriostatic agents. Not only is it unlikely that sufficient tissue levels of antibacterial agents will be attained, but the immune system of the poikilothermic species is not as efficient as that of the homeotherms. Antibody titers of poikilotherms are generally low and attained slowly (16) .
In view of the questionable value of these formulations in the therapy and prophylaxis of infections of ornamental fishes, and since it seems wise that all efforts should be directed towards reducing the selection pressures favoring antibiotic-resistant bacteria (15) , it would seem desirable to withdraw from the market products containing antibiotics used in human chemotherapy. This would contribute to the reduction in the reservoir of resistant bacteria in the environment.
